CANDESARTAN/HYDROCHLOROTHIAZIDE ZENTIVA 16 mg/12,5 mg, comprimé — plaquette(s) PVC PVDC aluminium de 30 comprimé(s)

Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France

  • CIP13 3400922090818
  • CIP7 2209081
  • CIS 60885214

What the source publishes

Holder
ZENTIVA FRANCE
Active ingredients
HYDROCHLOROTHIAZIDE, CANDÉSARTAN CILEXÉTIL
Form
comprimé
Package
plaquette(s) PVC PVDC aluminium de 30 comprimé(s)
Routes
orale
Administrative status
authorised
Supply regime
liste I
Marketing status
Déclaration de commercialisation
Authorised on
2012-02-21
Prescription
Prescription or restricted

Names this record is found by

Complete source data
fr:ansm:packages:3400922090818
{
  "cis": "60885214",
  "cip7": "2209081",
  "form": "comprimé",
  "name": "CANDESARTAN/HYDROCHLOROTHIAZIDE ZENTIVA 16 mg/12,5 mg, comprimé — plaquette(s) PVC PVDC aluminium de 30 comprimé(s)",
  "cip13": "3400922090818",
  "holder": "ZENTIVA FRANCE",
  "routes": [
    "orale"
  ],
  "holders": [
    "ZENTIVA FRANCE"
  ],
  "currency": "EUR",
  "marketed": true,
  "bdmStatus": null,
  "useDomain": "unknown",
  "publicPrice": "4.77",
  "authorisedOn": "2012-02-21",
  "compositions": [
    {
      "name": "HYDROCHLOROTHIAZIDE",
      "nature": "SA",
      "strength": "12,5 mg",
      "linkageNumber": "1",
      "substanceCode": "02064",
      "dosageReference": "un comprimé",
      "pharmaceuticalElement": "comprimé"
    },
    {
      "name": "CANDÉSARTAN CILEXÉTIL",
      "nature": "SA",
      "strength": "16 mg",
      "linkageNumber": "2",
      "substanceCode": "73594",
      "dosageReference": "un comprimé",
      "pharmaceuticalElement": "comprimé"
    }
  ],
  "sourceStatus": "Présentation active",
  "supplyRegime": "liste I",
  "dispensingFee": "1.02",
  "medicinePrice": "3.75",
  "regionalRules": "not-collected",
  "targetSpecies": [],
  "specialityName": "CANDESARTAN/HYDROCHLOROTHIAZIDE ZENTIVA 16 mg/12,5 mg, comprimé",
  "marketingStatus": "Déclaration de commercialisation",
  "publicationDates": {
    "CIS_bdpm": "2026-11-20",
    "CIS_CIP_bdpm": "2026-11-20",
    "CIS_CPD_bdpm": "2026-11-20",
    "CIS_COMPO_bdpm": "2026-11-20"
  },
  "specialityListed": true,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "fr.ansm.bdpm"
  },
  "collectiveApproval": "oui",
  "packageDescription": "plaquette(s) PVC PVDC aluminium de 30 comprimé(s)",
  "patientEligibility": "not-assessed",
  "reimbursementRates": [
    "65%"
  ],
  "marketingDeclaredOn": "2012-05-02",
  "targetSpeciesStatus": "not-reported",
  "additionalMonitoring": false,
  "administrativeStatus": "authorised",
  "prescriptionCategory": "prescription-or-restricted",
  "activeIngredientNames": [
    "HYDROCHLOROTHIAZIDE",
    "CANDÉSARTAN CILEXÉTIL"
  ],
  "authorisationProcedure": "Procédure décentralisée",
  "prescriptionConditions": [
    "liste I"
  ],
  "reimbursementIndications": null,
  "authorisationSourceStatus": "Autorisation active",
  "europeanAuthorisationNumber": null,
  "presentationAdministrativeStatus": "authorised"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=fr" \
  --data-urlencode "sourceId=fr.ansm.bdpm" \
  --data-urlencode "id=fr:ansm:packages:3400922090818"